---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-068647"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2026-06-01T12:59:50+00:00"
generated_at: "2026-06-01T13:01:34.778563+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# TransCode Therapeutics sets July 2, 2026 annual meeting; proposal deadline June 11

## Summary
- Annual meeting scheduled for July 2, 2026; record date May 28, 2026.
- Stockholder proposals for proxy inclusion due by June 11, 2026 (5:00 p.m. ET).
- Director nominations and other business notices also due by June 11, 2026.
- Meeting date moved more than 30 days from 2025 annual meeting (Aug 29, 2025).

## SEC filing metadata
- accession: 0001104659-26-068647
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2026-06-01T12:59:50+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465926068647/0001104659-26-068647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465926068647/tm2616319d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-068647
- JSON: https://secwatch.observer/filing/0001104659-26-068647.json
- Plain text: https://secwatch.observer/filing/0001104659-26-068647.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.